Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.4M Buy
451,100
+284,800
+171% +$46.3M 0.17% 89
2025
Q4
$32.4M Buy
166,300
+109,100
+191% +$26M 0.1% 137
2025
Q3
$16.1M Sell
57,200
-118,900
-68% -$30.3M 0.06% 242
2025
Q2
$38.5M Buy
176,100
+93,900
+114% +$15.2M 0.17% 71
2025
Q1
$11.5M Buy
82,200
+61,100
+290% +$9.95M 0.07% 209
2024
Q4
$3.52M Buy
21,100
+1,400
+7% +$249K 0.02% 522
2024
Q3
$3.36M Buy
19,700
+10,600
+116% +$1.54M 0.02% 638
2024
Q2
$1.28M Buy
+9,100
New +$1.13M 0.01% 901
2024
Q1
Sell
-37,300
Closed -$3.93M 2873
2023
Q4
$3.93M Buy
37,300
+26,800
+255% +$2.92M 0.03% 383
2023
Q3
$1.11M Buy
10,500
+8,800
+518% +$1.02M 0.01% 910
2023
Q2
$202K Sell
1,700
-2,800
-62% -$290K ﹤0.01% 1845
2023
Q1
$418K Sell
4,500
-600
-12% -$52.6K 0.01% 1506
2022
Q4
$416K Buy
+5,100
New +$388K 0.01% 1543
2022
Q2
Sell
-6,000
Closed -$496K 3509
2022
Q1
$496K Sell
6,000
-5,400
-47% -$437K ﹤0.01% 1768
2021
Q4
$994K Buy
11,400
+1,300
+13% +$122K 0.01% 1144
2021
Q3
$880K Buy
+10,100
New +$892K 0.01% 1443

Other funds holding ORCL

HRT Financial's ORCL Position: Q3 2025 in Review

HRT Financial sold out of Oracle (ORCL) in Q3 2025, closing a stake of 228,593 shares — an estimated $58.2M sold.

HRT Financial first reported a position in ORCL in Q3 2016 and held it in 23 quarters. The position peaked at $156M in Q1 2022. 3,820 funds tracked by Wall St. Rank hold ORCL as of Q3 2025.

  • HRT Financial reported no remaining Oracle position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 228,593 Oracle shares in Q3 2025, an estimated $58.2M.
  • HRT Financial first reported a position in Oracle in Q3 2016 and held it in 23 quarters.
  • HRT Financial's Oracle position peaked at $156M in Q1 2022.
  • 3,820 funds tracked by Wall St. Rank held Oracle as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.